These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18652443)

  • 1. Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes.
    Fotsch C; Wang M
    J Med Chem; 2008 Aug; 51(16):4851-7. PubMed ID: 18652443
    [No Abstract]   [Full Text] [Related]  

  • 2. Arthritis and endogenous glucocorticoids: the emerging role of the 11beta-HSD enzymes.
    Buttgereit F; Zhou H; Seibel MJ
    Ann Rheum Dis; 2008 Sep; 67(9):1201-3. PubMed ID: 18697779
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
    Andrews RC; Rooyackers O; Walker BR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):285-91. PubMed ID: 12519867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease.
    Walker BR; Seckl JR
    Expert Opin Ther Targets; 2003 Dec; 7(6):771-83. PubMed ID: 14640912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.
    Schnackenberg CG
    Curr Opin Investig Drugs; 2008 Mar; 9(3):295-300. PubMed ID: 18311666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity.
    Hughes KA; Webster SP; Walker BR
    Expert Opin Investig Drugs; 2008 Apr; 17(4):481-96. PubMed ID: 18363514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus.
    Li X; Wang J; Yang Q; Shao S
    Am J Med Sci; 2017 Oct; 354(4):408-414. PubMed ID: 29078846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the discovery of 11beta-HSD1 inhibitors.
    Boyle CD
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):495-511. PubMed ID: 18600567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase enzymes increases during the meiotic maturation of porcine oocytes.
    Webb RJ; Sunak N; Wren L; Michael AE
    Reproduction; 2008 Dec; 136(6):725-32. PubMed ID: 18787080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids and the insulin resistance syndrome.
    Siminialayi IM; Emem-Chioma PC
    Niger J Med; 2004; 13(4):330-5. PubMed ID: 15523856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting 11β-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease.
    Hardy RS; Seibel MJ; Cooper MS
    Curr Opin Pharmacol; 2013 Jun; 13(3):440-4. PubMed ID: 23540586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 11beta-hydroxysteroid dehydrogenase enzymatic activities by glycyrrhetinic acid in vivo supports direct glucocorticoid-mediated suppression of steroidogenesis in Leydig cells.
    Hu GX; Lin H; Sottas CM; Morris DJ; Hardy MP; Ge RS
    J Androl; 2008; 29(3):345-51. PubMed ID: 18187395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of 11beta-hydroxysteroid dehydrogenase expression by bombesin: a possible mechanism for glucocorticoid resistance in androgen independent prostate cancer.
    Lee JG; Ge R; Hardy DO; Leong K; Nanus DM; Hardy MP; Shen R
    Horm Metab Res; 2008 Nov; 40(11):772-8. PubMed ID: 18726827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity.
    London E; Castonguay TW
    J Nutr Biochem; 2009 Jul; 20(7):485-93. PubMed ID: 19443197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases.
    Su X; Lawrence H; Ganeshapillai D; Cruttenden A; Purohit A; Reed MJ; Vicker N; Potter BV
    Bioorg Med Chem; 2004 Aug; 12(16):4439-57. PubMed ID: 15265495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds.
    Blum A; Favia AD; Maser E
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):132-6. PubMed ID: 18822345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.
    Wan ZK; Chenail E; Xiang J; Li HQ; Ipek M; Bard J; Svenson K; Mansour TS; Xu X; Tian X; Suri V; Hahm S; Xing Y; Johnson CE; Li X; Qadri A; Panza D; Perreault M; Tobin JF; Saiah E
    J Med Chem; 2009 Sep; 52(17):5449-61. PubMed ID: 19673466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological roles of 11 beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase.
    White PC; Rogoff D; McMillan DR
    Curr Opin Pediatr; 2008 Aug; 20(4):453-7. PubMed ID: 18622204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
    Beseda I; Czollner L; Shah PS; Khunt R; Gaware R; Kosma P; Stanetty C; Del Ruiz-Ruiz MC; Amer H; Mereiter K; Da Cunha T; Odermatt A; Classen-Houben D; Jordis U
    Bioorg Med Chem; 2010 Jan; 18(1):433-54. PubMed ID: 19914836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.